Skip to main content
. 2018 Sep 28;9:465. doi: 10.3389/fpsyt.2018.00465

Table 1.

Clinical and behavioral description of the sample.

ICD- (n = 69) ICD+ (n = 31) p-value
Age, years 68.79 ± 7.82 63.55 ± 9.77 0.01
Gender, male (%) 37 (53.6) 17 (54.8) 0.91
Age at PD onset, years 62.5 ± 7.75 57.5 ± 9.52 0.02
Evolution, months 65.6 ± 3.76 77.8 ± 3.87 0.25
UPDRS III 23.4 ± 9.88 19.9 ± 9.65 0.11
H&Y* 2(2-2.5) 2(2-2) 0.06
LEDD, mg 533.1 ± 451.6 702.2 ± 416.9 0.07
Proportion of agonist use (%) 41 (59) 26 (84) 0.02
QUIPs 0.06 1.84 < 0.001
MIDI 0.29 3.3 < 0.001
BIS-11 56.35 ± 7.0 58.33 ± 7.72 0.23
 Motor 19.31 ± 2.52 19.37 ± 2.95 0.93
 Nonplanning 20.79 ± 4.07 22.23 ± 4.7 0.15
 Attentional 16.25 ± 1.98 16.73 ± 1.98 0.27
PCPT commission errors ratio 0.378 ± 0.2 0.376 ± 0.2 0.96
PCPT correct RT, ms 480 ± 75 465 ± 57 0.24
PCPT error RT, ms 447 ± 163 426 ± 131 0.49
PCPT correct targets ratio 0.94 0.95 0.59
Current smokers (%) 3 (4.3) 6 (19) 0.02**
Lifetime smokers (%) 32 (46) 20 (65) 0.93
Age at smoking onset 19.65 ± 4.48 15.53 ± 3.11 < 0.001
Current alcohol users (%) 41 (59) 27 (87) 0.006
Lifetime alcohol users (%) 52 (75) 30 (97) 0.009
Lifetime illegal drugs users (%) 3 (5) 4 (14) 0.20**

Mean ± standard deviation and proportions are shown unless otherwise specified. t-test is used for central measures and Chi-square for proportions unless other test specified.

*

Median (interquartile range), Wilcoxon–Mann–Whitney test significance is shown.

**

Fisher exact test significance is shown.

ICD, impulse control disorder; PD, Parkinson's disease; UPDRS, Unified Parkinson's Disease Rating Scale; H&Y Hoehn and Yahr scale; LEDD, levodopa equivalent daily dose; QUIPs, Short version of Questionnaire for Impulsive-Compulsive Disorders, MIDI, Minnesota Impulsive Disorders Interview; BIS-11, Barrat Impulsiveness Scale; PCPT, PEBL Continuous Performance Task; RT, reaction time; ms, milliseconds.